Found 4 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251729
(US10100018, Example 65 | US9464060, 65)Show SMILES CCCCN(Cc1ccc(cc1)C(=O)OC)C(=O)c1ccc(Oc2ccccc2OC)cc1 Show InChI InChI=1S/C27H29NO5/c1-4-5-18-28(19-20-10-12-22(13-11-20)27(30)32-3)26(29)21-14-16-23(17-15-21)33-25-9-7-6-8-24(25)31-2/h6-17H,4-5,18-19H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... |
US Patent US10100018 (2018)
BindingDB Entry DOI: 10.7270/Q2PR7Z0N |
More data for this Ligand-Target Pair | |
Lysophosphatidic acid receptor 5
(Homo sapiens (Human)) | BDBM251729
(US10100018, Example 65 | US9464060, 65)Show SMILES CCCCN(Cc1ccc(cc1)C(=O)OC)C(=O)c1ccc(Oc2ccccc2OC)cc1 Show InChI InChI=1S/C27H29NO5/c1-4-5-18-28(19-20-10-12-22(13-11-20)27(30)32-3)26(29)21-14-16-23(17-15-21)33-25-9-7-6-8-24(25)31-2/h6-17H,4-5,18-19H2,1-3H3 | UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... |
US Patent US9464060 (2016)
BindingDB Entry DOI: 10.7270/Q23R0RT0 |
More data for this Ligand-Target Pair | |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251729
(US10100018, Example 65 | US9464060, 65)Show SMILES CCCCN(Cc1ccc(cc1)C(=O)OC)C(=O)c1ccc(Oc2ccccc2OC)cc1 Show InChI InChI=1S/C27H29NO5/c1-4-5-18-28(19-20-10-12-22(13-11-20)27(30)32-3)26(29)21-14-16-23(17-15-21)33-25-9-7-6-8-24(25)31-2/h6-17H,4-5,18-19H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... |
US Patent US10100018 (2018)
BindingDB Entry DOI: 10.7270/Q2PR7Z0N |
More data for this Ligand-Target Pair | |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251729
(US10100018, Example 65 | US9464060, 65)Show SMILES CCCCN(Cc1ccc(cc1)C(=O)OC)C(=O)c1ccc(Oc2ccccc2OC)cc1 Show InChI InChI=1S/C27H29NO5/c1-4-5-18-28(19-20-10-12-22(13-11-20)27(30)32-3)26(29)21-14-16-23(17-15-21)33-25-9-7-6-8-24(25)31-2/h6-17H,4-5,18-19H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... |
US Patent US9464060 (2016)
BindingDB Entry DOI: 10.7270/Q23R0RT0 |
More data for this Ligand-Target Pair | |